As of May 28, 2025, P3 Health Partners Inc (PIII) reports a Net Margin of -9.05%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of P3 Health Partners Inc's Net Margin
Over recent years, P3 Health Partners Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -9.05% |
| 2023-12-31 | -4.56% |
| 2022-12-31 | -25.74% |
| 2021-12-31 | -24.55% |
| 2020-12-31 | -8.47% |
This fluctuation highlights how P3 Health Partners Inc manages its overall profitability and cost control over time.
Comparing P3 Health Partners Inc's Net Margin to Peers
To better understand P3 Health Partners Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| P3 Health Partners Inc (PIII) | -9.05% |
| Castle Biosciences Inc (CSTL) | 5.49% |
| Viemed Healthcare Inc (VMD.TO) | 4.47% |
| CVS Health Corp (CVS) | 1.24% |
| Cross Country Healthcare Inc (CCRN) | -1.08% |
| InnovAge Holding Corp (INNV) | -2.79% |
Compared to its competitors, P3 Health Partners Inc's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.